Benzene

Benzene

SCHEMBL8401599

CCc1ccn(CC(=O)O)c(=O)c1NC(=O)CCc1ccccc1.c1ccccc1

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.48
TP53 P04637 1/20 0.46
CASP1 P29466 1/20 0.46
MAPT P10636 3/20 0.46
HTT P42858 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.44
ATM Q13315 1/20 0.44
GAA P10253 3/20 0.44
RAB9A P51151 2/20 0.44
ALDH1A1 P00352 2/20 0.44
NPC1 O15118 1/20 0.44
F2 P00734 1/20 0.42
PRSS1 P07477 1/20 0.42
POLB P06746 1/20 0.41
KDM4E B2RXH2 1/20 0.41
HPGD P15428 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzene SCHEMBL8402446 0.80 ELANE (0.50) TSHRTP53MAPTSMN1; SMN2ATM
SCHEMBL949229 0.78 CASP1 (0.69) TSHRTP53CASP1MAPTHTT
SCHEMBL7474328 0.71 F2 (0.46) TSHRTP53MAPTHTTSMN1; SMN2
SCHEMBL7334849 0.70 KMT2A (0.42) MAPTSMN1; SMN2ATMALDH1A1F2
SCHEMBL15676772 0.69 GAA (0.73) TP53MAPTHTTSMN1; SMN2GAA
SCHEMBL27476686 0.69 CASP1 (0.61) TSHRTP53CASP1SMN1; SMN2GAA
SCHEMBL7483874 0.69 HDAC1 (0.41) MAPTSMN1; SMN2ALDH1A1F2PRSS1
SCHEMBL948489 0.68 CASP1 (0.70) CASP1MAPTHTTSMN1; SMN2RAB9A
SCHEMBL28553513 0.68 TSHR (0.60) TSHRMAPTHTTGAARAB9A
SCHEMBL10307779 0.68 ALDH1A1 (0.74) TSHRMAPTHTTSMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5973111-A NOVEL COMPOUNDS THAT ARE CAPABLE OF BINDING TO THE ACTIVE SITE OF INTERLEUKIN-1B-CONVERTING ENZYME (ICE) AND INHIBITING ACTIVITY OF THAT ENZYME; ADMINISTERING TO TREAT INFLAMMATORY, AUTOIMMUNE, AND NEURODEGENERATIVE DISEASES VERTEX PHARMACEUTICALS, INC. (US) 1999-10-26 US disclosed